Arlington VA 结直肠癌临床试验
52项针对 结直肠癌的研究正在 Arlington及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
招募中1 期
- NEXT Oncology Virginia, Fairfax · 距离 11 英里
The Vanguard Study: Testing a New Way to Screen for Cancer
招募中欢迎健康志愿者
- Inova Schar Cancer Institute, Fairfax · 距离 11 英里
- Inova Fair Oaks Hospital, Fairfax · 距离 11 英里
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
招募中2 期
- Virginia Cancer Specialists, Fairfax · 距离 11 英里
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
招募中1 期
- Inova Schar Cancer Institute, Fairfax · 距离 11 英里
- NEXT Virginia, Fairfax · 距离 11 英里
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
招募中1/2 期
- Virginia Cancer Specialists, Fairfax · 距离 11 英里
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
招募中1/2 期
- Inova Schar Cancer Institute, Fairfax · 距离 11 英里
- Virginia Cancer Specialists, PC, Fairfax · 距离 11 英里
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
招募中1 期
- ALX Center 2, Fairfax · 距离 11 英里
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
招募中3 期
- Virginia Cancer Specialists, PC, Arlington
- Virginia Cancer Specialists, PC, Fairfax · 距离 11 英里
- Virginia Cancer Specialists, PC, Reston · 距离 14 英里
- 以及另外 1 项
Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
招募中1/2 期
- NEXT Oncology, Fairfax · 距离 11 英里
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
招募中2 期
- Virginia Cancer Specialists - Fairfax /ID# 271351, Fairfax · 距离 11 英里
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
招募中3 期
- Virginia Cancer Specialists, Arlington
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
招募中3 期
- Virginia Cancer Specialists, Arlington
- Inova Schar Cancer Institute Dept of Fairfax Hospital, Fairfax · 距离 11 英里
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
招募中2/3 期
- Local Institution - 0278, Fairfax · 距离 11 英里
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
招募中1/2 期
- Virginia Cancer Specialists, Fairfax · 距离 11 英里
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
招募中1/2 期
- NEXT Oncology Virginia, Fairfax · 距离 11 英里
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
招募中1/2 期
- Next Oncology Virginia Cancer Specialist, Fairfax · 距离 11 英里
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
招募中1 期
- NEXT - Virginia, Fairfax · 距离 11 英里
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
招募中1/2 期
- NEXT Virginia, Fairfax · 距离 11 英里
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
招募中1 期
- NEXT Oncology, Fairfax · 距离 11 英里
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
招募中3 期
- Clinical Study Site, Fairfax · 距离 11 英里
A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer
招募中2 期
- Inova Schar Cancer, Fairfax · 距离 11 英里
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
招募中1 期
- NEXT Virginia, Fairfax · 距离 11 英里
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
招募中1 期
- NEXT Virginia, Fairfax · 距离 11 英里
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
招募中1 期
- NEXT Oncology, Fairfax · 距离 11 英里
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
招募中1 期
- NEXT Virginia, Fairfax · 距离 11 英里
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
招募中1/2 期
- Clinical Trial Site, Fairfax · 距离 11 英里
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
招募中1/2 期
- Virginia Cancer Specialists, Fairfax · 距离 11 英里
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
招募中1/2 期
- NEXT Virginia, Fairfax · 距离 11 英里
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
招募中1/2 期
- Virginia Cancer Specialists, Fairfax · 距离 11 英里
AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
招募中1 期
- Next Virginia, Fairfax · 距离 11 英里
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
招募中1 期
- Virginia Cancer Specialists, Fairfax · 距离 11 英里
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
招募中2 期
- Inova Schar Cancer Institute - Fairfax - Innovation Park Drive /ID# 274586, Fairfax · 距离 11 英里
- Virginia Cancer Specialists - Fairfax /ID# 274339, Fairfax · 距离 11 英里
A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
招募中1 期
- NEXT Virginia, Fairfax · 距离 11 英里
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
招募中1/2 期
- NEXT Oncology Virginia, Fairfax · 距离 11 英里
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
招募中1 期
- NEXT Virginia, Fairfax · 距离 11 英里
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
招募中1 期
- NEXT Texas LLC - Virginia, Fairfax · 距离 11 英里
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
招募中1 期
- NEXT Virginia, Fairfax · 距离 11 英里
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
招募中1 期
- Research Site, Fairfax · 距离 11 英里
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
招募中1 期
- NEXT Oncology Virginia, Fairfax · 距离 11 英里
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
招募中1/2 期
- NEXT Virginia, Fairfax · 距离 11 英里
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
招募中1 期
- NEXT Oncology Virginia, Fairfax · 距离 11 英里
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
招募中1/2 期
- Next Oncology Virginia, Fairfax · 距离 11 英里
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
招募中1/2 期
- NEXT Virginia, Fairfax · 距离 11 英里
A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
招募中1 期
- NEXT Virginia, LLC, Fairfax · 距离 11 英里
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
招募中1/2 期
- Virginia Cancer Specialists, Fairfax · 距离 11 英里
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
招募中1/2 期
- Virginia Cancer Specialists, Fairfax · 距离 11 英里
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
招募中1/2 期
- Virginia Cancer Specialists, Fairfax · 距离 11 英里
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
招募中1/2 期
- NEXT Virginia, Fairfax · 距离 11 英里
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
招募中1/2 期
- NEXT, Virginia, Fairfax · 距离 11 英里
A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors
招募中1 期
- NEXT Virginia, Fairfax · 距离 11 英里
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
招募中1 期
- Virginia Cancer Specialists, Fairfax · 距离 11 英里
A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors
招募中1 期
- Next Oncology, Virginia Cancer Specialists, Fairfax · 距离 11 英里
其他城市的 结直肠癌试验
- Houston, TX102 项研究
- New York City, NY78 项研究
- Nashville, TN69 项研究
- Boston, MA63 项研究
- Los Angeles, CA59 项研究
- St. Louis, MO50 项研究
- San Antonio, TX46 项研究
- Philadelphia, PA44 项研究
- Grand Rapids, MI40 项研究
- Baldwin Park, CA37 项研究
- Chicago, IL34 项研究
- Tampa, FL34 项研究
Arlington的其他研究
- 非小细胞肺癌104 项研究
- 转移性癌症53 项研究
- 癌症（所有类型）48 项研究
- 乳腺癌47 项研究
- 卵巢癌46 项研究
- 肺癌41 项研究
- 子宫内膜癌39 项研究
- 胰腺癌33 项研究
- 头颈鳞状细胞癌26 项研究
- 小细胞肺癌23 项研究
- 胃癌20 项研究
- 三阴性乳腺癌20 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。